DOW JONES22,309.48+1256.95 5.97%
S&P 5002,632.36+143.71 5.77%
NASDAQ7,790.71+417.63 5.66%

Goldman Sachs Downgrades Ovintiv to Neutral, Announces $2.25 Price Target

Goldman Sachs analyst Brian Singer downgrades Ovintiv (NYSE:OVV) from Buy to Neutral and announces $2.25 price target.

Benzinga · 03/16/2020 09:26

Goldman Sachs analyst Brian Singer downgrades Ovintiv (NYSE:OVV) from Buy to Neutral and announces $2.25 price target.